The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2022 | ELCC 2022: an opportunity for discussion and new perspectives
Vera Pancaldi, PhD, Institut Universitaire du Cancer de Toulouse – Oncopole, Toulouse, France, discusses what she is most looking forward to at the European Lung Cancer Congress 2022, including the opportunity to discuss with doctors to provide new perspectives on how best to use computational tools to ultimately improve patient lives and treatment approaches. This interview took place during the virtual European Lung Cancer Congress 2022.
